The Cleveland Clinic Center for Osteoporosis and Metabolic Bone Disease is devoted to the evaluation and treatment of patients with osteoporosis and other forms of diseases that affect bone. Over 28 million people have osteoporosis; there are more than 1.5 million fractures which occur annually in this country at a total cost of over 13 billion dollars to the health care system. A woman’s lifetime risk for having a fracture is over 50%.
Since a woman has a greater than 50% chance of having a fracture, this is an important disease to evaluate and treat as early as possible. Osteoporosis is often called a silent disease because bone loss occurs without symptoms. The first symptom is often a fracture. By that time, a woman has often lost 30% or more of her bone mass. If evaluated at an early stage, patients can initiate prevention and treatment prior to the clinical manifestations of this silent disease.
Our goal is to evaluate patients at an early stage to prevent the complications of osteoporosis, and treat patients at the earliest possible stage to prevent additional disease manifestations.
The Center sees patients with osteoporosis, disorders of calcium metabolism, and other metabolic bone diseases. The center has a state of the art bone densitometer, a Lunar Prodigy, which is used to assess bone density in the hip and spine, as well as radius and total body if clinically indicated. This technique allows the physicians to evaluate the degree of bone loss, to diagnose osteoporosis and the risk for future fracture.
Visit one of the links above to learn more about our center.
To make an appointment with a physician in the Center for Osteoporosis and Metabolic Bone Disease, call 866.275.7496.
